Osteosarcoma Treatment: A Journey into the Tumor Microenvironment | Emanuela Palmerini, MD, PhD

Emanuela Palmerini, M.D., Ph.D.

Professor of Clinical Medicine

University of Miami Miller School of Medicine

Dr. Palmerini is a medical oncologist and international expert in bone and soft tissue sarcomas. She is Full Professor of Sarcoma Research at the Miller School of Medicine and a member of the Sarcoma and Phase I Programs at Sylvester Comprehensive Cancer Center. She has led or contributed to more than 30 sarcoma clinical trials and has played key roles in major European research networks, including the EORTC Bone Sarcoma Group, the Euro-Ewing Consortium, and as co-Chair of the FOSTER osteosarcoma consortium. She has authored over 200 scientific publications.

Analyze current and emerging therapeutic strategies in osteosarcoma, including MAP chemotherapy, mifamurtide, and novel immunotherapies such as ADCs and T-cell engagers.

Recognize the prognostic relevance of the tumor microenvironment, particularly the impact of CD8+ T cells, NK cells, Tregs, and CD4+ infiltration on survival.

Apply patient-centered, multidisciplinary decision-making through sarcoma expert consultation.

Accreditation

The University of Miami Leonard M. Miller School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

The University of Miami Leonard M. Miller School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program.